125 related articles for article (PubMed ID: 18606348)
1. Profound hypothermia secondary to normal ziprasidone use.
Gibbons GM; Wein DA; Paula R
Am J Emerg Med; 2008 Jul; 26(6):737.e1-2. PubMed ID: 18606348
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotic medication as a cause of deep hypothermia].
van Marum RJ; Jansen S; Ponssen HH
Ned Tijdschr Geneeskd; 2003 Jun; 147(25):1201-4. PubMed ID: 12848053
[TBL] [Abstract][Full Text] [Related]
3. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone.
Zaidi AN
Ann Pharmacother; 2005 Oct; 39(10):1726-31. PubMed ID: 16131536
[TBL] [Abstract][Full Text] [Related]
5. Ziprasidone-associated depressive state in schizophrenic patients.
Kaptsan A; Dwolatzky T; Lerner V
Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
[TBL] [Abstract][Full Text] [Related]
6. Urticaria and angio-oedema due to ziprasidone.
Akkaya C; Sarandol A; Aydogan K; Kirli S
J Psychopharmacol; 2007 Jul; 21(5):550-2. PubMed ID: 17446198
[TBL] [Abstract][Full Text] [Related]
7. Acute dystonia after initial doses of ziprasidone: a case report.
Yumru M; Savas HA; Selek S; Savas E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
[TBL] [Abstract][Full Text] [Related]
8. [Recurrent dysregulation of body temperature during antipsychotic pharmacotherapy].
Löffler S; Danos P; Schillen TB; Klimke A
Psychiatr Prax; 2008 Mar; 35(2):91-3. PubMed ID: 17902059
[TBL] [Abstract][Full Text] [Related]
9. Hypothermia induced by atypical neuroleptics.
Schwaninger M; Weisbrod M; Schwab S; Schröder M; Hacke W
Clin Neuropharmacol; 1998; 21(6):344-6. PubMed ID: 9844790
[TBL] [Abstract][Full Text] [Related]
10. Probable association between ziprasidone and worsening hypertension.
Villanueva N; Markham-Abedi C; McNeely C; Diaz FJ; de Leon J
Pharmacotherapy; 2006 Sep; 26(9):1352-7. PubMed ID: 16945059
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone-induced galactorrhea: a case report.
Kopecek M; Bares M; Mohr P
Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
[TBL] [Abstract][Full Text] [Related]
12. Pediatric ziprasidone overdose.
Fasano CJ; O'Malley GF; Lares C; Rowden AK
Pediatr Emerg Care; 2009 Apr; 25(4):258-9. PubMed ID: 19369840
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
14. Ziprasidone-induced tardive laryngeal dystonia: a case report.
Tsai CS; Lee Y; Chang YY; Lin PY
Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
[TBL] [Abstract][Full Text] [Related]
15. Possible long-acting risperidone-induced hypothermia precipitating phenytoin toxicity in an elderly patient.
Brandon Bookstaver P; Miller AD
J Clin Pharm Ther; 2011 Jun; 36(3):426-9. PubMed ID: 21545623
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.
Neves G; Kliemann M; Betti AH; Conrado DJ; Tasso L; Fraga CA; Barreiro EJ; Teresa Dalla Costa ; Rates SM
Pharmacol Biochem Behav; 2008 Mar; 89(1):23-30. PubMed ID: 18082872
[TBL] [Abstract][Full Text] [Related]
17. A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.
Akkaya C; Sarandol A; Sivrioglu EY; Kotan Z; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1535-8. PubMed ID: 16820256
[TBL] [Abstract][Full Text] [Related]
18. Unintentional ingestion of ziprasidone in a 22-month-old.
MacVane CZ; Baumann MR
Pediatr Emerg Care; 2009 Jul; 25(7):460-2. PubMed ID: 19606003
[TBL] [Abstract][Full Text] [Related]
19. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
Scott LK; Green R; McCarthy PJ; Conrad SA
J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732
[TBL] [Abstract][Full Text] [Related]
20. Ziprasidone-induced tardive dyskinesia in a patient without known risk factors.
Sinha P; Rao R; Sharan P
Natl Med J India; 2007; 20(5):271-2. PubMed ID: 18254531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
